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Abstract
Background: Prions, infectious agents associated with prion diseases such as Creutzfeldt-Jakob disease in humans, bovine
spongiform encephalopathy (BSE) in cattle, and scrapie in sheep and goats, are primarily comprised of PrP
Sc, a protease-
resistant misfolded isoform of the cellular prion protein PrP
C. Protein misfolding cyclic amplification (PMCA) is a highly
sensitive technique used to detect minute amounts of scrapie PrP
Sc. However, the current PMCA technique has been
unsuccessful in achieving good amplification in cattle. The detailed distribution of PrP
Sc in BSE-affected cattle therefore
remains unknown.
Methodology/Principal Findings: We report here that PrP
Sc derived from BSE-affected cattle can be amplified ultra-
efficiently by PMCA in the presence of sulfated dextran compounds. This method is capable of amplifying very small
amounts of PrP
Sc from the saliva, palatine tonsils, lymph nodes, ileocecal region, and muscular tissues of BSE-affected cattle.
Individual differences in the distribution of PrP
Sc in spleen and cerebrospinal fluid samples were observed in terminal-stage
animals. However, the presence of PrP
Sc in blood was not substantiated in the BSE-affected cattle examined.
Conclusions/Significance: The distribution of PrP
Sc is not restricted to the nervous system and can spread to peripheral
tissues in the terminal disease stage. The finding that PrP
Sc could be amplified in the saliva of an asymptomatic animal
suggests a potential usefulness of this technique for BSE diagnosis. This highly sensitive method also has other practical
applications, including safety evaluation or safety assurance of products and byproducts manufactured from bovine source
materials.
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Introduction
Prions, the infectious agents associated with transmissible spongi-
form encephalopathies such as scrapie in sheep, chronic wasting
disease (CWD) in deer and elk, bovine spongiform encephalopathy
(BSE), and Creutzfeldt-Jakob disease (CJD) in humans, are primarily
comprised of PrP
Sc, a protease-resistant misfolded isoform of the
cellular prion protein PrP
C [1]. Prion diseases are fatal neurodegen-
erative disorders, and are characterized by the accumulation of PrP
Sc
in the nervous tissues of infected subjects [2].
BSE is an emerging disease that first appeared in the United
Kingdom in 1986 [3]. The cause of the BSE outbreak in the UK is
believed to have been the result of feeding cattle meat and bone
meal (MBM) contaminated with PrP
Sc acquired from rendering
carcasses of BSE- or scrapie-infected ruminants [4,5]. Since
variant CJD (vCJD) is suspected to be attributable to infectious
agents associated with BSE [6–8], prophylactic hygiene dictates
that infected cattle be identified and eradicated.
Immunological methods such as enzyme-linked immunosorbent
assays and western blotting (WB) have been widely used for the
detection of PrP
Sc. It is now possible to perform in vitro
amplification of hamster scrapie PrP
Sc using the protein misfolding
cyclic amplification (PMCA) technique [9]. Extremely small
amounts of PrP
Sc can be detected by combining PMCA with
WB [10,11]. PMCA has been used to amplify PrP
Sc from mice
[12], deer [13], sheep [14], and humans [15]. PMCA has also
been applied to the detection of bovine PrP
Sc in cattle [16], and
serial PMCA has been shown to improve detection sensitivity [17].
Although hyperefficient amplification of a mouse-adapted BSE
strain has been demonstrated [18], there are no reports that cite
ultrasensitive and direct detection of bovine PrP
Sc in cattle using
the current PMCA method.
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13152Since the concentration of PrP
Sc in tissues or body fluids of
BSE-infected animals is expected to be extremely low, the
development of a sensitive method for detecting PrP
Sc in infected
cattle is important. In the present study, we developed an
extremely efficient method that is suitable for bovine PrP
Sc
amplification. The method, which involves amplifying BSE PrP
Sc
in the presence of sulfated dextran compounds, enables sensitive
detection of PrP
Sc at levels equivalent to those obtained for
detection of hamster PrP
Sc [19]. This method is capable of
amplifying very small amounts of PrP
Sc from the saliva, palatine
tonsils, lymph nodes, ileocecal region, and muscular tissues of
BSE-affected cattle. The technology will result in a marked
improvement in BSE safety.
Results
Sulfated dextran compounds enhanced BSE PrP
Sc
amplification
In general, the efficiency of BSE PrP
Sc amplification using
PMCA was low compared to amplification of hamster and mouse
scrapie PrP
Sc (Figure 1A). We attempted to improve BSE PrP
Sc
amplification efficiency using high temperature conditions (39uC
and higher). Various reagents were screened for their ability to
prevent thermal denaturation of the brain homogenate, and we
found that sulfated dextran compounds were suitable for this
purpose. Unexpectedly, the BSE PrP
Sc amplification efficiency was
greatly increased when amplification was performed in the
presence of sulfated dextran compounds at 37uC.
The signal intensities of amplified PrP
Sc upon WB were
significantly higher in samples containing sodium dextran sulfate
with a high molecular weight of 900–2000 kDa (DSS-H) at a
final concentration of 0.25–1% (Figure 1A, right panel). This
enhancement was dependent upon the polarity and molecular size
of the dextran compound. Smaller anionic sodium dextran sulfate
(DSS-L) and potassium dextran sulfate (DSP) were more effective
than the high molecular weight compounds, but positively charged
DEAE-dextran and dextrans covering a range of molecular
weights had little or no effect on amplification (Figure 1B).
Glycosaminoglycans that are distributed throughout animal tissues
and a sulfated polysaccharide were not effective at the concentra-
tions examined (Figure 1C).
In contrast, in vitro amplification of sheep scrapie PrP
Sc was
completely inhibited by the addition of DSP to the reaction
mixture (Figure 2A). A similarly inconsistent experimental result
Figure 1. The effect of polysaccharides on the amplification of PrP
Sc derived from BSE-affected cattle. A. The effect of sodium dextran
sulfate with a high molecular weight (MW) ranging from 900 to 2000 kDa (sodium dextran sulfate, DSS-H) on BSE-PrP
Sc amplification. The PrP
Sc seed
(10% brain homogenate) was diluted to 10
22 to 10
23 in PrP
C substrate, and the diluted samples were amplified in the presence of DSS-H at 0–1%.
The samples before (left panel) and after (right panel) amplification were analyzed by WB after digestion with PK. ‘‘N’’ designates controls in which
the PrP
C substrate alone was treated in the same manner. B. The effect of dextran compounds on BSE-PrP
Sc amplification. The PrP
Sc seed was diluted
to 10
24, and amplification was performed in the presence or absence (‘‘No additive’’) of dextran compounds at 0.5%. ‘‘No seed’’ designates the
control in which the PrP
C substrate alone was amplified without dextran compounds. DSS-L: sodium dextran sulfate with a low MW, ranging from 5
to 6 kDa; DSP: potassium dextran sulfate (1.5 to 1.9 kDa); DEAE-dextran hydrochloride (50 kDa); dextran I (15–20 kDa), II (35–50 kDa), III (50–70 kDa),
IV (200 kDa), and V (190–230 kDa). C. The effect of glycosaminoglycans (sodium chondroitin sulfate C: CSS; sodium heparan sulfate: HSS; heparan
sulfate proteoglycan: HSPG) and a sulfated polysaccharide (l-carrageenan: l-Cag) on BSE-PrP
Sc amplification. The PrP
Sc seed was diluted to 10
24, and
amplification was performed in the presence of each reagent at the final concentration indicated in the figure.
doi:10.1371/journal.pone.0013152.g001
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effective in treating CJD [20,21]. This reagent acted as an
inhibitor of sheep scrapie PrP
Sc amplification (Figure 2A), but
induced a low-level, dose-dependent amplification of BSE PrP
Sc
(Figure 2B).
Detection limit of BSE PrP
Sc using DSP-PMCA techniques
The optimal concentration of DSP was estimated to be in the
range of 0.05–0.75% (Figure 3); therefore, we used 0.5% DSP for
subsequent experiments. We determined the detection limit of the
DSP-PMCA technique and confirmed that PrP
Sc present in a
10
26 dilution of infected brain homogenate could be detected after
one round of amplification, and both 10
28 and 10
29 dilutions
tested positive for PrP
Sc after two rounds of amplification
(Figure 4A). A PrP
Sc signal was detected in one of the 10
210
dilution samples, but no signal was detected in the more extreme
dilution range, even after four rounds of amplification. Thus, the
PrP
Sc detection sensitivity was improved 10
8 times compared to no
amplification. The 50% lethal dose (LD50) per gram of brain
homogenate used as seed was determined in a previous study [22]
by a bioassay using Tg(BoPrP)4092HOZ/Prnp
0/0 (TgBoPrP)
transgenic mice [23]. The infectious titer was 10
6.7 LD50/g, and
infectivity was confirmed in mice intracerebrally inoculated with
up to a 10
24 dilution of the 10% brain homogenate. Therefore,
our improved method was 10
5 times more sensitive than the
bioassay. The generation of spontaneous PrP
Sc, as has been
reported for amplification in the presence of polyanions [24,25],
was not observed with four rounds of amplification (Figure 4B).
Infectivity of the PMCA product
The PMCA product obtained after six rounds of amplification
was diluted 10-fold and inoculated intracerebrally into TgBoPrP
transgenic mice that overexpress bovine PrP
C. Mice inoculated
with the PMCA sample died after a mean of 243 days (Table 1).
Control mice administered DSP (0.05%) or PrP
Sc (3.2610
212
dilution) at concentrations corresponding to the BSE seed dilution
in the PMCA sample survived more than 500 days. The results of
immunohistochemical analysis of the habenular nuclei and the
midbrains from control and treated mice are shown in Figure 5.
Vacuolation and PrP
Sc accumulation, which was occasionally
observed as plaque-like PrP
Sc aggregates, were found in mice
inoculated with the PMCA sample or the BSE-affected cattle brain
Figure 2. The effect of DSP and PPS on the amplification of scrapie and BSE PrP
Sc.A . The PrP
Sc seed (10% brain homogenate from scrapie-
infected sheep) was diluted to 10
23, and amplification was performed in the presence or absence (‘‘No additive’’) of sulfated compounds (potassium
dextran sulfate: DSP and pentosan polysulfate: PPS). ‘‘No seed’’ designates the control in which PrP
C substrate (10% homogenate of normal mouse
brain) was amplified without sulfated compounds. B. Negative symbols indicate the results obtained for the control samples without BSE PrP
Sc seed,
while positive symbols indicate the results obtained for the samples containing BSE PrP
Sc seed diluted to 10
24. Amplification was performed in the
presence of PPS at the concentrations indicated.
doi:10.1371/journal.pone.0013152.g002
Figure 3. Optimal DSP concentration for BSE PrP
Sc amplification. The PrP
Sc seed was diluted to 10
24, and amplification was performed in the
presence of the potassium dextran sulfate (DSP). ‘‘N’’ designates the control in which only PrP
C substrate was amplified.
doi:10.1371/journal.pone.0013152.g003
PrP
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Sc was infectious
and caused lesions typical of prion diseases.
PrP
Sc distribution in the tissues of BSE-affected cattle
Using our improved method, the distribution of PrP
Sc was
examined in cattle that were orally administered a brain
homogenate prepared from BSE-infected cattle. In the terminal
disease stage in BSE-affected cow 5550, PrP
Sc was detected by
conventional WB in several peripheral nervous tissues and the
adrenal glands (Table 2). Moreover, PrP
Sc was detected by serial
DSP-PMCA in the palatine tonsils, lymph nodes, ileocecal region,
and muscular tissues (Figure 6A), whereas no PrP
Sc signal was
detected in the corresponding tissue samples from uninfected
control cow 2914 (Table 2 and Figure 6B).
We could not detect PrP
Sc in the spleen, blood, or cerebrospinal
fluid (CSF) from BSE-affected cow 5550 in the end stage of
disease, even after four rounds of amplification. Although an
additional five tissue pieces were cut from both the central portion
of the spleen and the splenic hilum for amplification, splenic PrP
Sc
was not detected in any of these 10 tissue samples (Figure 7A). The
distribution of PrP
Sc in the spleen was examined further in two
more terminal disease-stage BSE-affected cattle, numbers 5499
Figure 4. BSE-PrP
Sc detection sensitivity. A. The PrP
Sc seed was diluted to 10
24 to 10
211 with PrP
C substrate, and samples were serially amplified
in the presence of 0.5% potassium dextran sulfate (DSP). The duplicate amplified samples were analyzed after each round of amplification (R1–R4) by
WB after PK digestion. B. No spontaneous generation of PrP
Sc was observed. Samples labeled ‘‘1’’ to ‘‘8’’ contained only PrP
C substrate and were
amplified in the presence of 0.5% DSP.
doi:10.1371/journal.pone.0013152.g004
Table 1. Mean incubation time of TgBoPrP mice following intracerebral inoculation.
Inocula Transmission rate (total death/total number)
Mean incubation time ± SD
(days)
DSP dilution control (0.05%) 0% (0/3) .532
BSE PrP
Sc dilution control (3.2610
212) 0% (0/9) .532
R6 PMCA product 100% (9/9) 24368
doi:10.1371/journal.pone.0013152.t001
PrP
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Results from mice inoculated with a 10% brain homogenate from BSE-infected cattle are shown for comparison. No vacuolation or PrP
Sc
accumulation was observed in the control mice inoculated with 0.05% DSP.
doi:10.1371/journal.pone.0013152.g005
Table 2. Detection of PrP
Sc by conventional WB analysis.
Cow Number
2914
660 5499 5468 5550 9007
Months post administration Control
34
(p.o.)
42
(p.o.)
57
(p.o.)
17
(i.c.)
Clinical status at dissection Normal Affected Affected Affected Asymptomatic
Medulla oblongata – ++++
Spinal cord (cervical) – ++++
Spinal cord (thoracic) – ++++
Spinal cord (lumbar) – ++++
Palatine tonsil ––––N D
Spleen ––––N D
Mesenteric lymph node ––––N D
Rouviere lymph node ––––N D
Vagus nerve (cervical) – – ++ND
Sympathetic nerve (thoracic) ––––N D
Stellate ganglion – +++ND
Radial nerve ––––N D
Ischiatic nerve ––––N D
Adrenal gland – – ++ND
Lingual radix ––––N D
Triceps brachii muscle ––––N D
Semitendinosus muscle ––––N D
Ileocecal region ––––N D
White blood cells –––––
Plasma –––––
Cerebrospinal fluid –––––
p.o.: peroral inoculation; i.c.: intracerebral inoculation. Negative symbols indicate that no PrP
Sc signal was detected in the samples before amplification. Positive symbols
indicate that typical PrP
Sc signals were detected in the samples. ND: not determined.
doi:10.1371/journal.pone.0013152.t002
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Sc was not
detected in any of the 10 tissue samples from cow 5499 (Figure 7B).
However, a PrP
Sc signal was detected in 3 of 10 tissue pieces from
the spleen of cow 5468 (Figure 7C).
PrP
Sc distribution in the bodily fluids of BSE-affected
cattle
Before amplification, PrP
Sc accumulation was confirmed using
conventional WB analysis in the peripheral nervous tissues of cows
5499 and 5468 and in the adrenal gland of cow 5468 (Table 2).
Individual differences in the distribution of PrP
Sc in CSF samples were
observed in terminal-stage animals. PrP
Sc signals were detected in
duplicate samples from cow 5468 after three rounds of amplification
(Figure 7C) but were not detected in samples from cow 5499
(Figure 7B), as confirmed in samples from cow 5550 (Figure 6A).
We also examined the distribution of PrP
Sc in the salivary
glands and saliva obtained from BSE-affected cattle. PrP
Sc was
detected in the submandibular and parotid glands of cows 5468
and 5499 after two rounds of amplification (Figure 8A). In cow
5550, PrP
Sc was detected in the submandibular and sublingual
glands (Figure 8B). Moreover, a PrP
Sc signal was detected in two of
the quadruplicate saliva samples from cow 5550 after four rounds
of amplification. The presence or absence of salivary PrP
Sc was
investigated in intracerebrally infected cow 9007. PrP
Sc accumu-
lation in the brain stem was found by conventional WB analysis 17
months after inoculation (Table 2), but the animal remained
asymptomatic until sacrifice. PrP
Sc was detected in the sublingual
and parotid glands after two rounds of amplification. In cow 9007,
one of the duplicate saliva samples was found to be positive for
PrP
Sc after four rounds of amplification (Figure 8C).
Figure 6. Distribution of PrP
Sc in cattle inoculated with BSE. A. Tissue distribution of PrP
Sc in the terminal disease stage in cow 5550.
Quadruplicate samples of each tissue and bodily fluid were serially amplified, and the samples were analyzed after each round of amplification (R1–
R4) by WB after digestion with PK. Horizontal lines indicate the positions of molecular weight markers corresponding to 37 kDa, 25 kDa, 20 kDa, and
15 kDa. Ns: No seed control. B. Negative control reaction for serial PMCA in each tissue. Quadruplicate samples of each tissue and bodily fluid from
uninfected cow 2914 were serially amplified, and the samples were analyzed by WB following digestion with PK after each round of amplification. C:
Cervical region, T: Thoracic region, L: Lumbar region, nt: Not tested.
doi:10.1371/journal.pone.0013152.g006
PrP
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The present study is the first report describing ultrasensitive
detection of BSE PrP
Sc in cattle. The determination that sulfated
dextran compounds enhance the efficiency of in vitro BSE PrP
Sc
amplification was unexpected because sulfated dextran has long been
known as an antiscrapie agent both invivo [26] and in vitro [27]. In vitro
studies using recombinant PrP [28] and PrP
C purified from brain
homogenate [29] have suggested that various polyanionic com-
pounds increase the amplification of protease-resistant PrP. There-
fore, endogenous polyanionic molecules such as sulfated glycans
[28,29] and RNA [29] could be cofactors required to facilitate the
propagation of PrP
Sc. Small and negatively charged dextran
compounds (DSP and DSS-L) were most effective for in vitro
amplification ofbovine PrP
Sc inthisstudy.Thesedextrancompounds
may accelerate the rate of PrP
Sc formation by acting as accessory
molecules that facilitate or stabilize interactions between PrP
Sc,P r P
C
and cofactors contained in brain homogenates. Since species-specific
differences in cofactor preference for in vitro amplification of PrP
Sc
have been reported [30], dextran compounds may interfere with
PrP
Sc formation by acting as competitive inhibitors of the cofactors
required for propagation of scrapie PrP
Sc.
The theory that PrP
Sc is widely distributed in various peripheral
tissues in the terminal disease stage is strongly supported by our
Figure 7. PrP
Sc in spleen and bodily fluid samples obtained in the terminal disease stage. A total of 10 tissue pieces (0.2 g each) were cut
from the central portion of the spleen (a–e) and splenic hilum (f–j) for amplification. Duplicate samples of spleen tissue from BSE-affected cows 5550
(A), 5499 (B), and 5468 (C) were examined. Blood and CSF samples from cows 5499 (B) and 5468 (C) were also examined. Horizontal lines indicate the
positions of molecular weight markers corresponding to 37 kDa, 25 kDa, 20 kDa, and 15 kDa. WBC: White blood cells, CSF: Cerebrospinal fluid, Ns: No
seed control.
doi:10.1371/journal.pone.0013152.g007
Figure 8. Detection of PrP
Sc by serial DSP-PMCA in saliva and salivary glands. Salivary PrP
Sc was evaluated in samples from an uninfected
control cow (5660) and samples obtained from BSE-inoculated cows (5468, 5499, and 5550) in the terminal disease stage. Salivary PrP
Sc was also
evaluated in an asymptomatic cow (9007) that had been intracerebrally inoculated with BSE. Horizontal lines indicate the positions of molecular
weight markers corresponding to 37 kDa, 25 kDa, 20 kDa, and 15 kDa. Ns: No seed control.
doi:10.1371/journal.pone.0013152.g008
PrP
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strated a low level of infectivity in the tonsils [31] and muscles [32]
of cattle that were orally administered a brain homogenate
prepared from BSE-infected cattle. With regard to the level of
PrP
Sc detected in muscle tissue, the level estimated from the
amplification factor in PMCA was lower than that found in a brain
homogenate diluted to 10
26 because no PrP
Sc signal was detected
in the first round of amplification. In the mesenteric and Rouviere
lymph nodes as well as the ileocecal region, only one or two of the
quadruplicate samples tested positive, even after four rounds of
amplification. Given that PrP
Sc tends to aggregate, partial
detection of PrP
Sc in the reaction may be due to the near absence
of PrP
Sc; PrP
Sc levels in these tissues would have been equivalent
to the levels found in brain homogenate dilutions of 10
210 to
10
211.
Although significant prionemia [33] and PrP
Sc distribution in
the blood [34] have been demonstrated in scrapie-infected
animals, the presence of PrP
Sc in the blood was not substantiated
in the BSE-affected cattle used in our study, despite a dramatic
improvement in the sensitivity of PrP
Sc detection. This observation
was in agreement with the previous result showing that the disease
is not transmitted through the blood of BSE-affected cattle
[32,35]. Together with the scattered accumulation of PrP
Sc in the
spleen and the low-level accumulation of PrP
Sc in the lymph
nodes, the absence of detectable PrP
Sc in the blood of BSE-
affected cattle suggests a neuronal rather than lymphoreticular
progression of BSE PrP
Sc to the brain.
With regard to other bodily fluids, a bioassay of saliva from
CWD-affected deer showed significant levels of infectious prions
[36]. The presence of PrP
Sc in the salivary glands [37] and the
amplification of PrP
Sc in concentrated buccal swab samples [38]
have been reported in scrapie-infected sheep. Ours is the first
report describing PrP
Sc detection in both the salivary glands and
saliva of BSE-infected cattle. The salivary glands are regulated by
parasympathetic nerves arising from the salivary nuclei of the
medulla oblongata and sympathetic nerves arising from the
thoracic portion of the spinal cord. Thus, it is possible that PrP
Sc
accumulated in the central nervous system and spread to the
salivary glands through the autonomic nervous system, and that
very small amounts of PrP
Sc were secreted into the saliva in BSE-
infected cattle.
Our study demonstrated that the distribution of PrP
Sc was not
restricted to the nervous system, and that PrP
Sc was able to spread
to most of the peripheral tissues examined in the terminal disease
stage. The finding that PrP
Sc could be amplified in saliva taken
from an asymptomatic animal suggests a potential usefulness of
this technique for BSE diagnosis. Detailed examinations of the
temporal course of BSE infection and the incidence of PrP
Sc
appearance in saliva, as well as studies of how infection route
affects salivary PrP
Sc accumulation, will be necessary to confirm
whether salivary PrP
Sc can serve as a reliable marker for BSE
infection. The highly sensitive method we describe has other
practical applications as well, such as evaluating the safety of
livestock products and raw feed materials, and safety assurance of
pharmaceutical and cosmetic products manufactured from bovine
source materials.
Materials and Methods
Ethics Statement
All animal experiments were approved by the Animal Care and
Use Committee (approval IDs: 450 and 08-009) and Animal
Ethics Committee (approval IDs: 04-III-7 and 08-IV-32) of the
National Institute of Animal Health.
Cattle
The cattle used in this study were imported from Australia. A c-
BSE-infected brain homogenate (50 ml of a 10% homogenate) was
orally administered to cattle (cows 5499, 5468, and 5550) ranging
from 10 to 12 months in age. After 34 to 57 months, the animals
were sacrificed and dissected in the terminal disease stage. Cow
9007 was intracerebrally inoculated with c-BSE-infected brain
homogenate (1 ml of a 10% homogenate), sacrificed and dissected
17 months following inoculation, and the tissues were used for the
analysis of salivary PrP
Sc. Normal 3- to 4- month-old cattle (cows
2914 and 5660) were used as controls.
Sample preparation
Tissues, white blood cells (WBCs), plasma, serum, CSF, and
saliva were collected upon dissection and stored in small aliquots at
280uC. Oral cavity saliva was collected by aspiration. Samples
from each tissue (0.2 g) and WBCs (approximately 2610
8 cells)
were homogenized and suspended at 20% (w/v) in phosphate-
buffered saline (PBS) containing 26complete protease inhibitors
(Roche Diagnostics).
PrP
C substrate
To avoid contamination, brain homogenates were prepared in a
laboratory that had never contained infected materials. The brains
of bovine PrP
C-overexpressing TgBoPrP transgenic mice and
PrP knockout (PrP
0/0) mice were homogenized separately in 20%
(w/v) PBS containing 26 complete protease inhibitors. The
homogenates were mixed with an equal volume of elution buffer
(PBS containing 2% Triton X-100 and 8 mM EDTA) and
incubated at 4uC for 1 h with continuous agitation. After
centrifugation at 45006g for 5 min, the supernatants were mixed
in a 5:1 proportion of PrP
0/0:TgBoPrP. This mixture was used as
the PrP
C substrate. Dextrans (Nacalai), dextran compounds
(sodium dextran sulfate (DSS), potassium dextran sulfate (DSP),
Nacalai; DEAE-dextran, Sigma), pentosan polysulfate (PPS,
Elmiron, Janssen-Ortho), sulfated polysaccharide (l-carrageenan
(l-Cag), Nacalai), glycosaminoglycans (sodium chondroitin sulfate
C (CSS), sodium heparan sulfate (HSS), Nacalai), and heparan
sulfate proteoglycan (HSPG, Sigma) were dissolved in PBS or
distilled water and added to the PrP
C substrate at the
concentration indicated in the figures. For the amplification of
sheep scrapie PrP
Sc, normal ICR mouse brains were homogenized
in 10% (w/v) PBS containing complete protease inhibitors, 1%
Triton X-100, and 4 mM EDTA. After centrifugation at 45006g
for 5 min, the supernatant was used as the PrP
C substrate.
PMCA
To examine the bovine PrP
Sc detection sensitivity, 100 mlo f
PrP
C substrate containing 0.5% DSP was mixed with 1/100
volume of 10% brain homogenate from cattle infected with c-BSE
(infectivity titer =10
6.7 LD50/g) [20], and serial 10-fold dilutions
were prepared of the PrP
C substrate containing 0.5% DSP.
Homogenates of each tissue and WBCs, plasma, serum, CSF, and
saliva were diluted 1:20 with the PrP
C substrate containing 0.5%
DSP (total volume 100 ml) in an electron beam-irradiated
polystyrene tube. Amplification was performed with a fully
automatic cross-ultrasonic protein-activating apparatus (Elestein
070-CPR, Elekon Science Corporation) using 40 cycles of
sonication in which a 3-s pulse oscillation was repeated five times
at 1-s intervals, followed by incubation at 37uC for 1 h with
agitation. For the amplification of PrP
Sc in various tissues from
BSE-inoculated and control cattle (Figure 6), the PrP
C substrate
containing 0.5% DSP was mixed with 1/20 volume of
PrP
Sc Detection in BSE Cattle
PLoS ONE | www.plosone.org 8 October 2010 | Volume 5 | Issue 10 | e13152homogenized samples or bodily fluids (total volume 80 ml) in an
electron beam-irradiated 8-strip polystyrene tube specially de-
signed for PrP
Sc propagation. PMCA was performed using 40
cycles of sonication (a pulse oscillation for 5 s, repeated five times
at 1-s intervals), followed by incubation at 37uC for 1 h with
agitation. The 1:5 dilution of the PMCA product and subsequent
amplification was repeated three times.
Western blotting
Samples (10 ml) were mixed with 10 ml of proteinase K (PK)
solution (100 mg/ml) after each round of amplification and
incubated at 37uC for 1 h. The digested materials were mixed
with 20 mlo f2 6SDS sample buffer and incubated at 100uC for
5 min. The samples were separated by SDS-PAGE and
transferred onto a polyvinylidene fluoride membrane (Millipore).
After blocking, the membrane was incubated for 1 h with a
horseradish peroxidase (HRP)-conjugated T2 monoclonal anti-
body [39] diluted 1:10 000. After washing, the blotted membrane
was developed using the Immobilon Western Chemiluminescent
HRP Substrate (Millipore) according to the manufacturer’s
instructions. Chemiluminescence signals were analyzed with a
Light Capture system (Atto).
Bioassay
A 10% brain homogenate from c-BSE-infected cows was diluted
to 10
28 with PrP
C substrate containing 0.5% DSP and amplified.
The PMCA product was diluted 1:5 with the PrP
C source
containing 0.5% DSP, and a second round of amplification was
performed. The 1:5 dilution of the PMCA product and its
subsequent amplification were repeated five times. The product
from the sixth round was diluted 1:10 with PBS and inoculated
intracerebrally into TgBoPrP mice (20 ml per mouse). The PrP
C
substrate containing 0.05% DSP and the PrP
C substrate
containing the PrP
Sc seed diluted to 3.2610
212 were inoculated
as dilution controls for DSP and the PrP
Sc seed, respectively.
Immunohistological analysis
The left hemisphere of the brain was fixed in 10% buffered
formalin for neuropathological analysis. Coronal brain sections
were immersed in 98% formic acid to reduce infectivity and
embedded in paraffin wax. Sections of 4-mm thickness were cut
and stained with hematoxylin and eosin (HE). Immunoreactive
PrP
Sc was detected in brain sections using anti-PrP monoclonal
antibody F99/97.6.1 (VMRD) or 12F10 (SPI-bio) as the primary
antibody. An anti-mouse universal immunoperoxidase polymer
(Histofine simple stain MAX-PO (M), Nichirei) was used as the
secondary antibody, and 3,39-diaminobenzidine tetrachloride
served as the chromogen.
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